Literature DB >> 27484935

Editorial: dark chocolate may improve NAFLD and metabolic syndrome by reducing oxidative stress.

H Malhi1, R Loomba2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27484935      PMCID： PMC4975527          DOI： 10.1111/apt.13716

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  9 in total

Review 1.  Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.

Authors:  Federico Salomone; Justyna Godos; Shira Zelber-Sagi
Journal:  Liver Int       Date:  2015-11-05       Impact factor: 5.828

Review 2.  The global NAFLD epidemic.

Authors:  Rohit Loomba; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-17       Impact factor: 46.802

3.  Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis.

Authors:  Jeffrey W Molloy; Christopher J Calcagno; Christopher D Williams; Frances J Jones; Dawn M Torres; Stephen A Harrison
Journal:  Hepatology       Date:  2011-12-22       Impact factor: 17.425

4.  NADPH Oxidases in Chronic Liver Diseases.

Authors:  Joy X Jiang; Natalie J Török
Journal:  Adv Hepatol       Date:  2014-11-30

Review 5.  The cardiovascular benefits of dark chocolate.

Authors:  Asimina Kerimi; Gary Williamson
Journal:  Vascul Pharmacol       Date:  2015-05-27       Impact factor: 5.773

6.  Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver.

Authors:  Santhosh Satapati; Blanka Kucejova; Joao A G Duarte; Justin A Fletcher; Lacy Reynolds; Nishanth E Sunny; Tianteng He; L Arya Nair; Kenneth A Livingston; Kenneth Livingston; Xiaorong Fu; Matthew E Merritt; A Dean Sherry; Craig R Malloy; John M Shelton; Jennifer Lambert; Elizabeth J Parks; Ian Corbin; Mark A Magnuson; Jeffrey D Browning; Shawn C Burgess
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

Review 7.  Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis.

Authors:  M Noureddin; Q M Anstee; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2016-04-08       Impact factor: 8.171

8.  Effects of dark chocolate on NOX-2-generated oxidative stress in patients with non-alcoholic steatohepatitis.

Authors:  L Loffredo; M Del Ben; L Perri; R Carnevale; C Nocella; E Catasca; F Baratta; F Ceci; L Polimeni; P Gozzo; F Violi; F Angelico
Journal:  Aliment Pharmacol Ther       Date:  2016-06-06       Impact factor: 8.171

Review 9.  Clinical benefit and preservation of flavonols in dark chocolate manufacturing.

Authors:  Andrew McShea; Emma Ramiro-Puig; Sandra B Munro; Gemma Casadesus; Margarida Castell; Mark A Smith
Journal:  Nutr Rev       Date:  2008-11       Impact factor: 7.110
  9 in total
  1 in total

1.  Associations between dietary total antioxidant capacity and odds of non-alcoholic fatty liver disease (NAFLD) in adults: a case-control study.

Authors:  Mohammad Hassan Sohouli; Somaye Fatahi; Aliakbar Sayyari; Beheshteh Olang; Farzad Shidfar
Journal:  J Nutr Sci       Date:  2020-11-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.